These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33297953)
21. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517 [TBL] [Abstract][Full Text] [Related]
22. Huntingtin Supplies a csaA-Independent Function Essential for EDTA-Resistant Homotypic Cell Adhesion in Dictyostelium discoideum. Thompson MN; MacDonald ME; Gusella JF; Myre MA J Huntingtons Dis; 2014; 3(3):261-71. PubMed ID: 25300330 [TBL] [Abstract][Full Text] [Related]
23. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity. Khoshnan A; Ko J; Patterson PH Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1002-7. PubMed ID: 11792860 [TBL] [Abstract][Full Text] [Related]
24. Translating Antisense Technology into a Treatment for Huntington's Disease. Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033 [TBL] [Abstract][Full Text] [Related]
25. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model. van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347 [TBL] [Abstract][Full Text] [Related]
26. In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington's disease. Casaca-Carreira J; Toonen LJA; Evers MM; Jahanshahi A; van-Roon-Mom WMC; Temel Y Biomed Pharmacother; 2016 Dec; 84():93-96. PubMed ID: 27639545 [TBL] [Abstract][Full Text] [Related]
27. Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic. Miniarikova J; Evers MM; Konstantinova P Mol Ther; 2018 Apr; 26(4):947-962. PubMed ID: 29503201 [TBL] [Abstract][Full Text] [Related]
28. Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates. Yan Y; Peng D; Tian J; Chi J; Tan J; Yin X; Pu J; Xia K; Zhang B Sci China Life Sci; 2011 Apr; 54(4):342-50. PubMed ID: 21509658 [TBL] [Abstract][Full Text] [Related]
30. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195 [TBL] [Abstract][Full Text] [Related]
31. Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I. Ceccon A; Tugarinov V; Ghirlando R; Clore GM Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5844-5852. PubMed ID: 32127471 [TBL] [Abstract][Full Text] [Related]
32. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904 [TBL] [Abstract][Full Text] [Related]
33. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197 [TBL] [Abstract][Full Text] [Related]
34. Clues to γ-secretase, huntingtin and Hirano body normal function using the model organism Dictyostelium discoideum. Myre MA J Biomed Sci; 2012 Apr; 19(1):41. PubMed ID: 22489754 [TBL] [Abstract][Full Text] [Related]
35. A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles. Southwell AL; Skotte NH; Villanueva EB; Østergaard ME; Gu X; Kordasiewicz HB; Kay C; Cheung D; Xie Y; Waltl S; Dal Cengio L; Findlay-Black H; Doty CN; Petoukhov E; Iworima D; Slama R; Ooi J; Pouladi MA; Yang XW; Swayze EE; Seth PP; Hayden MR Hum Mol Genet; 2017 Mar; 26(6):1115-1132. PubMed ID: 28104789 [TBL] [Abstract][Full Text] [Related]
36. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Banerjee M; Datta M; Bhattacharyya NP Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155 [TBL] [Abstract][Full Text] [Related]
37. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models. Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246 [TBL] [Abstract][Full Text] [Related]